Eric T. Sun

1.4k total citations
20 papers, 1.0k citations indexed

About

Eric T. Sun is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eric T. Sun has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eric T. Sun's work include Chemical Synthesis and Analysis (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Cancer-related Molecular Pathways (4 papers). Eric T. Sun is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Cancer-related Molecular Pathways (4 papers). Eric T. Sun collaborates with scholars based in United States and Singapore. Eric T. Sun's co-authors include Daniel H. Rich, E H Ulm, Anthony D. William, Brian Dymock, Ramesh Jayaraman, Kantharaj Ethirajulu, Daniel J. Garland, Paul H. Taghert, Kee Chuan Goh and D. S. KEMP and has published in prestigious journals such as The Journal of Comparative Neurology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Eric T. Sun

20 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric T. Sun United States	16	596	265	264	191	125	20	1.0k
Shin‐ichi Tsukamoto Japan	22	765 1.3×	147 0.6×	652 2.5×	119 0.6×	139 1.1×	71	1.6k
Haile Tecle United States	14	1.1k 1.9×	403 1.5×	423 1.6×	161 0.8×	42 0.3×	27	1.7k
Wang‐Qing Liu France	20	805 1.4×	283 1.1×	194 0.7×	122 0.6×	48 0.4×	54	1.2k
Roland Neuhaus Germany	16	732 1.2×	191 0.7×	123 0.5×	193 1.0×	54 0.4×	35	1.1k
Geoffrey Lawton United Kingdom	13	904 1.5×	166 0.6×	275 1.0×	176 0.9×	48 0.4×	20	1.4k
Roland Feifel Switzerland	21	769 1.3×	164 0.6×	338 1.3×	206 1.1×	41 0.3×	36	1.3k
Kelli Glenn United States	13	895 1.5×	690 2.6×	182 0.7×	126 0.7×	69 0.6×	20	1.4k
Paul Rose United States	17	634 1.1×	329 1.2×	94 0.4×	124 0.6×	77 0.6×	21	1.1k
Karima Bettayeb France	18	731 1.2×	316 1.2×	397 1.5×	101 0.5×	59 0.5×	21	1.5k
Christopher H. Hill United Kingdom	14	960 1.6×	152 0.6×	353 1.3×	177 0.9×	49 0.4×	22	1.5k

Countries citing papers authored by Eric T. Sun

Since Specialization

Citations

This map shows the geographic impact of Eric T. Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric T. Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric T. Sun more than expected).

Fields of papers citing papers by Eric T. Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric T. Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric T. Sun. The network helps show where Eric T. Sun may publish in the future.

Co-authorship network of co-authors of Eric T. Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Eric T. Sun. A scholar is included among the top collaborators of Eric T. Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric T. Sun. Eric T. Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poulsen, Anders, Anthony D. William, Stéphanie Blanchard, et al.. (2012). Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3). Journal of Molecular Modeling. 19(1). 119–130. 29 indexed citations

William, Anthony D., Anders Poulsen, Kee Chuan Goh, et al.. (2012). Discovery of the Macrocycle (9E)-15-(2-(Pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a Potent Inhibitor of Janus Kinase 2/Fms-LikeTyrosine Kinase-3 (JAK2/FLT3) for the Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry. 55(6). 2623–2640. 36 indexed citations

Novotny‐Diermayr, Veronica, Stefan Hart, Yung Kiang Loh, et al.. (2011). TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties. Leukemia. 26(2). 236–243. 105 indexed citations

William, Anthony D., Kee Chuan Goh, Stéphanie Blanchard, et al.. (2011). Discovery of Kinase Spectrum Selective Macrocycle (16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs), Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the Treatment of Cancer. Journal of Medicinal Chemistry. 55(1). 169–196. 78 indexed citations

William, Anthony D., Stéphanie Blanchard, Anders Poulsen, et al.. (2011). Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma. Journal of Medicinal Chemistry. 54(13). 4638–4658. 149 indexed citations

Blanchard, Stéphanie, Anthony D. William, Anders Poulsen, et al.. (2010). Synthesis and evaluation of alkenyl indazoles as selective Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(8). 2443–2447. 15 indexed citations

Wang, Haishan, Yan Zhou, Ting Lu, et al.. (2010). Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity. Bioorganic & Medicinal Chemistry Letters. 20(11). 3314–3321. 24 indexed citations

Poulsen, Anders, Anthony D. William, Stéphanie Blanchard, et al.. (2008). Structure-based design of Aurora A & B inhibitors. Journal of Computer-Aided Molecular Design. 22(12). 897–906. 8 indexed citations

Li, Haitao, Kenna Anderes, Eugenia Kraynov, et al.. (2006). Discovery of a Novel, Orally Active, Small Molecule Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist. Journal of Medicinal Chemistry. 49(11). 3362–3367. 14 indexed citations

10.

Sun, Eric T., et al.. (1993). An immunocytochemical study of the FMRFamide neuropeptide gene products in Drosophila. The Journal of Comparative Neurology. 337(3). 446–460. 81 indexed citations

11.

Vazquez, Michael L., Danny J. Garland, Eric T. Sun, et al.. (1992). Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive (NMDA) receptor antagonist, in vitro and in vivo. Neuroscience Letters. 135(2). 149–152. 4 indexed citations

12.

Rao, Tadimeti S., Julie A. Cler, Robert P. Compton, et al.. (1990). Neuropharmacological characterization of 1-Aminocyclopropane-1-carboxylate and 1-Aminocyclobutane-1-carboxylate, Ligands of the N-Methyl-D-Aspartate-associated Glycine Receptor. Neuropharmacology. 29(3). 305–309. 28 indexed citations

13.

Wood, Paul L., Tadimeti S. Rao, Smriti Iyengar, et al.. (1990). A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/Glycine/Ion channel receptor macrocomplex. Neurochemical Research. 15(2). 217–230. 54 indexed citations

14.

Hood, William F., et al.. (1989). 1-Aminocyclobutane-1-carboxylate (ACBC): a specific antagonist of the N-methyl-D-aspartate receptor coupled glycine receptor. European Journal of Pharmacology. 161(2-3). 281–282. 47 indexed citations

15.

KEMP, D. S. & Eric T. Sun. (1982). Amino acids derivatives that stabilize secondary structures of polypeptides--. Tetrahedron Letters. 23(37). 3759–3760. 40 indexed citations

16.

Rich, Daniel H., Eric T. Sun, & E H Ulm. (1980). Synthesis of analogs of the carboxyl protease inhibitor pepstatin. Effect of structure on inhibition of pepsin and renin. Journal of Medicinal Chemistry. 23(1). 27–33. 119 indexed citations

17.

Rich, Daniel H. & Eric T. Sun. (1980). Mechanism of inhibition of pepsin by pepstatin. Biochemical Pharmacology. 29(16). 2205–2212. 68 indexed citations

18.

Rich, Daniel H., et al.. (1979). ChemInform Abstract: SYNTHESIS OF (3S,4S)‐4‐AMINO‐3‐HYDROXY‐6‐METHYLHEPTANOIC ACID DERIVATIVES. ANALYSIS OF DIASTEREOMERIC PURITY. Chemischer Informationsdienst. 10(8). 15 indexed citations

19.

Rich, Daniel H., et al.. (1978). Synthesis of (3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid derivatives. Analysis of diastereomeric purity. The Journal of Organic Chemistry. 43(18). 3624–3626. 81 indexed citations

20.

Rich, Daniel H., Eric T. Sun, & Jasbir Singh. (1977). Synthesis of dideoxy-pepstatin. Mechanism of inhibition of porcine pepsin. Biochemical and Biophysical Research Communications. 74(2). 762–767. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact